Filing Details

Accession Number:
0001104659-24-006670
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-01-25 16:10:26
Reporting Period:
2024-01-23
Accepted Time:
2024-01-25 16:10:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
727207 Accelerate Diagnostics Inc AXDX Laboratory Analytical Instruments (3826) 841072256
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1021413 John Patience C/O Accelerate Diagnostics, Inc.
3950 S. Country Club Road, Suite 470
Tucson AZ 85714
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-01-23 16,666 $0.00 453,224 No 4 P Indirect By John Patience Living Trust dated 7/23/1993
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By John Patience Living Trust dated 7/23/1993
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock Warrants (right to buy) Acquisiton 2024-01-23 16,666 $0.00 16,666 $1.65
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
16,666 2024-01-23 2029-01-23 No 4 P Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 3,941 Indirect By IRA
Common Stock 214,046 Indirect By Patience Enterprises LP
Footnotes
  1. The reported securities are included within 16,666 units of the issuer (the "Units") purchased by the reporting person for $1.50 per Unit in an underwritten public offering. Each Unit consists of one share of the issuer's common stock and one warrant to purchase one share of the issuer's common stock.
  2. The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.